Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b

Author:

Fitzgerald Kathryn C.1,Munger Kassandra L.1,Köchert Karl2,Arnason Barry G. W.3,Comi Giancarlo4,Cook Stuart5,Goodin Douglas S.6,Filippi Massimo7,Hartung Hans-Peter8,Jeffery Douglas R.9,O’Connor Paul10,Suarez Gustavo11,Sandbrink Rupert12,Kappos Ludwig13,Pohl Christoph14,Ascherio Alberto15

Affiliation:

1. Department of Nutrition, Harvard T. H. Chan School of Public Health, Harvard University, Boston, Massachusetts

2. Bayer Pharma AG, Berlin, Germany

3. Department of Neurology, University of Chicago, Chicago, Illinois

4. Department of Neurology, Scientific Institute H. S. Raffaele, Milan, Italy

5. Department of Neurology and Neuroscience, Rutgers–New Jersey Medical School, Newark

6. Department of Neurology, University of California, San Francisco

7. Neuroimaging Research Unit, Scientific Institute and University Vita-Salute, Milan, Italy

8. Department of Neurology, University of Dusseldorf, Dusseldorf, Germany

9. Department of Neurology, Piedmont Health Care, Mooresville, North Carolina

10. Department of Neurology, St Michael’s Hospital, Toronto, Ontario, Canada

11. Bayer HealthCare Pharmaceuticals, Whippany, New Jersey

12. Bayer Pharma AG, Berlin, Germany12Bayer Pharma AG, Berlin, Germany

13. Department of Neurology, University Hospital Basel, Basel, Switzerland

14. Bayer Pharma AG, Berlin, Germany14Department of Neurology, University Hospital Bonn, Bonn, Germany

15. Department of Nutrition, Harvard T. H. Chan School of Public Health, Harvard University, Boston, Massachusetts15Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Subject

Neurology (clinical)

Cited by 125 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Vitamin D and the epidemiology of multiple sclerosis;Feldman and Pike's Vitamin D;2024

2. Epidemiology, epigenetics, and etiological factors in multiple sclerosis;Clinical Aspects of Multiple Sclerosis Essentials and Current Updates;2024

3. An update on combination therapies for multiple sclerosis: where are we now?;Expert Review of Neurotherapeutics;2023-12-02

4. MULTIPLE SCLEROSIS: AN EMERGENCY MEDICINE-FOCUSED NARRATIVE REVIEW;The Journal of Emergency Medicine;2023-12

5. Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis;Gut Microbes;2023-11-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3